MedTrace Logo

Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

NCT07245667 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-11-28

No results posted yet for this study

Summary

This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).

Conditions

  • Tinea Pedis

Interventions

DRUG

1% Tolnaftate Stick Formula A

Topical antifungal stick containing 1% tolnaftate in the Formula A base. Applied twice daily for 4 weeks.

DRUG

1% Tolnaftate Stick Formula B

Topical antifungal stick containing 1% tolnaftate in the Formula B base. Applied twice daily for 4 weeks.

DRUG

1% Tolnaftate Stick Formula C

Topical antifungal stick containing 1% tolnaftate in the PP2C-2003 base formulation. Applied twice daily for 30 days.

Sponsors & Collaborators

  • Propedix, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-30
Primary Completion
2026-02-28
Completion
2026-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07245667 on ClinicalTrials.gov